184 related articles for article (PubMed ID: 35776395)
1. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma.
Hua N; Chen A; Yang C; Dong H; He X; Ru G; Tong X; Zhou F; Wang S
Mol Biol Rep; 2022 Aug; 49(8):7911-7919. PubMed ID: 35776395
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.
Son Y; Shin NR; Kim SH; Park SC; Lee HJ
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069373
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8
Guo M; Yuan F; Qi F; Sun J; Rao Q; Zhao Z; Huang P; Fang T; Yang B; Xia J
J Transl Med; 2020 Aug; 18(1):306. PubMed ID: 32762721
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma.
Yang C; Qian Q; Zhao Y; Huang B; Chen R; Gong Q; Ji H; Wang C; Xia L; You Z; Zhang J; Chen X
Front Immunol; 2023; 14():1112672. PubMed ID: 36993960
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma.
Yao XM; Zhang FH; Liu Y
Bull Exp Biol Med; 2023 Apr; 174(6):774-778. PubMed ID: 37162630
[TBL] [Abstract][Full Text] [Related]
7. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.
Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E
Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Serum FGL1 as Diagnostic Markers for HBV-Related Hepatocellular Carcinoma.
Cai X; Tang D; Chen J; Li H; Zhang P
Lab Med; 2023 May; 54(3):270-281. PubMed ID: 36219698
[TBL] [Abstract][Full Text] [Related]
9. Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti-Lag-3 via reducing FGL1 expression.
Wang J; Wei W; Tang Q; Lu L; Luo Z; Li W; Lu Y; Pu J
Cancer Med; 2020 Oct; 9(19):7125-7136. PubMed ID: 32810392
[TBL] [Abstract][Full Text] [Related]
10. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
11. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
Jiang SS; Weng DS; Wang QJ; Pan K; Zhang YJ; Li YQ; Li JJ; Zhao JJ; He J; Lv L; Pan QZ; Xia JC
J Transl Med; 2014 Sep; 12():273. PubMed ID: 25260879
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma.
Yan Q; Lin HM; Zhu K; Cao Y; Xu XL; Zhou ZY; Xu LB; Liu C; Zhang R
Front Oncol; 2022; 12():810269. PubMed ID: 35273912
[TBL] [Abstract][Full Text] [Related]
17. Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma.
Lin M; He J; Zhang X; Sun X; Dong W; Zhang R; Xu Y; Lv L
J Clin Invest; 2023 May; 133(9):. PubMed ID: 37115693
[TBL] [Abstract][Full Text] [Related]
18. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
